LA JOLLA PHARMACEUTICAL CO Interest Expense, Other
LA JOLLA PHARMACEUTICAL CO reported Interest Expense, Other of $2.37 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2022-08-15
- LA JOLLA PHARMACEUTICAL CO interest expense, other for the quarter ending 2022-06-30 was $2.37M, a 11.23% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO interest expense, other for the quarter ending 2022-03-31 was $2.40M, a 7.93% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO interest expense, other for the quarter ending 2021-12-31 was $2.45M, a 7.59% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO interest expense, other for the quarter ending 2021-09-30 was $2.73M, a 8.04% increase year-over-year.
- LA JOLLA PHARMACEUTICAL CO interest expense, other for fiscal 2021 was $10.46M, a 4.05% increase from fiscal 2020.
- LA JOLLA PHARMACEUTICAL CO interest expense, other for fiscal 2020 was $10.05M, a 6.71% decline from fiscal 2019.
- LA JOLLA PHARMACEUTICAL CO interest expense, other for fiscal 2019 was $10.77M.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month | Interest Expense, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2022-06-30 | $2.37M 10-Q · filed 2022-08-15 | $4.77M 10-Q · filed 2022-08-15 | $7.22M derived: sum of 3 quarters · filed 2022-08-15 | $9.95M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2022-03-31 | $2.40M 10-Q · filed 2022-05-16 | $4.85M derived: sum of 2 quarters · filed 2022-05-16 | $7.58M derived: sum of 3 quarters · filed 2022-05-16 | $10.25M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $5.18M derived: sum of 2 quarters · filed 2022-03-09 | $7.85M derived: sum of 3 quarters · filed 2022-08-15 | $10.46M 10-K · filed 2022-03-09 | |
| 2021-09-30 | $2.73M 10-Q · filed 2021-11-04 | $5.40M derived: sum of 2 quarters · filed 2022-08-15 | $8.01M 10-Q · filed 2021-11-04 | $10.66M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-06-30 | $2.67M 10-Q · filed 2022-08-15 | $5.28M 10-Q · filed 2022-08-15 | $7.93M derived: sum of 3 quarters · filed 2022-08-15 | $10.46M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $2.61M 10-Q · filed 2022-05-16 | $5.26M derived: sum of 2 quarters · filed 2022-05-16 | $7.78M derived: sum of 3 quarters · filed 2022-05-16 | $10.25M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $5.17M derived: sum of 2 quarters · filed 2022-03-09 | $7.64M derived: sum of 3 quarters · filed 2022-03-09 | $10.05M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $2.53M 10-Q · filed 2021-11-04 | $5.00M derived: sum of 2 quarters · filed 2021-11-04 | $7.40M 10-Q · filed 2021-11-04 | $9.78M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $2.47M 10-Q · filed 2021-08-05 | $4.88M 10-Q · filed 2021-08-05 | $7.25M derived: sum of 3 quarters · filed 2021-08-05 | $10.12M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $2.41M 10-Q · filed 2021-05-07 | $4.78M derived: sum of 2 quarters · filed 2021-05-07 | $7.64M derived: sum of 3 quarters · filed 2021-05-07 | $10.45M derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $5.24M derived: sum of 2 quarters · filed 2021-03-08 | $8.04M derived: sum of 3 quarters · filed 2021-03-08 | $10.77M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $2.86M 10-Q · filed 2020-11-09 | $5.67M derived: sum of 2 quarters · filed 2020-11-09 | $8.40M 10-Q · filed 2020-11-09 | $9.35M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $2.81M 10-Q · filed 2020-08-06 | $5.54M 10-Q · filed 2019-08-01 | $6.49M derived: sum of 3 quarters · filed 2020-08-06 | $9.41M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $2.73M 10-Q · filed 2020-05-04 | $3.68M derived: sum of 2 quarters · filed 2020-08-06 | $6.61M derived: sum of 3 quarters · filed 2020-08-06 | $8.26M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2018-12-31 | $954.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2020-08-06 | $3.88M derived: sum of 2 quarters · filed 2020-08-06 | $5.53M derived: sum of 3 quarters · filed 2020-08-06 | $5.54M 10-Q · filed 2020-08-06 | $7.30M 10-K · filed 2020-03-02 |
| 2018-09-30 | $2.93M 10-Q · filed 2019-11-12 | $4.58M derived: sum of 2 quarters · filed 2019-11-12 | $4.58M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $1.65M 10-Q · filed 2019-08-01 | $1.65M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-06 |